Movement toward Environmentally Friendly Pharmaceuticals in Japan
Kei Nagai1,2
1Department of Nephrology, Division of Clinical Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.
JMA Journal
|November 9, 2023
Summary
Japanese pharmaceutical companies are reducing greenhouse gas (GHG) emissions through various strategies. Supporting these environmentally friendly practices is crucial for sustainable growth in the healthcare sector.
Area of Science:
- Environmental Science
- Health Economics
- Pharmaceutical Science
Background:
- Healthcare activities, including pharmaceutical manufacturing, contribute significantly to greenhouse gas (GHG) emissions.
- In Japan, the healthcare sector accounts for approximately 5% of total GHG emissions, with pharmaceuticals representing a substantial portion.
- GHG emissions in drug manufacturing are categorized into Scope 1 (direct), Scope 2 (energy indirect), and Scope 3 (supply chain indirect).
Purpose of the Study:
- To examine the efforts of Japanese pharmaceutical companies in reducing GHG emissions.
- To highlight the importance of corporate sustainability initiatives within the pharmaceutical industry.
- To encourage stakeholder engagement, including healthcare providers and consumers, in promoting environmentally friendly pharmaceuticals.
Main Methods:
- Analysis of GHG emission scopes (1, 2, and 3) in pharmaceutical manufacturing.
- Review of sustainability strategies employed by Japanese pharmaceutical companies.
- Evaluation of corporate environmental performance and certifications (e.g., Carbon Disclosure Project).
Main Results:
- Japanese pharmaceutical companies are actively pursuing GHG emission reduction goals, with many achieving high rankings globally in sustainability.
- Common strategies include facility consolidation, renewable energy adoption, eco-friendly logistics, simplified packaging, and supply chain optimization.
- Despite high emissions goals, variations exist due to operational differences among companies.
Conclusions:
- Consumer and healthcare provider support is vital for the success of pharmaceutical companies' environmental conservation efforts.
- Market mechanisms, such as prescribing drugs with lower environmental impact, can drive the development of sustainable pharmaceuticals.
- Clinicians play a key role in recognizing corporate environmental stewardship and fostering a sustainable pharmaceutical industry.
Related Concept Videos
01:25Drug Regulation
1.4K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.4K
01:02Prescription, Nonprescription and Orphan Drugs
742
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
742
01:16Drug Biotransformation: Overview
2.4K
Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
2.4K
00:46Bioremediation
18.6K
Bioremediation is the use of prokaryotes, fungi, or plants to remove pollutants from the environment. This process has been used to remove harmful toxins in groundwater as a byproduct of agricultural run-off and also to clean up oil spills.
18.6K
01:27Effects of Chemicals: Overview
1.3K
Drugs, encompassing various chemical compounds from natural sources, lab synthesis, or genetic engineering, elicit different biological responses in living organisms. Some of these responses are desirable or therapeutic, while others are undesirable. The primary goal of administering a drug is to achieve a therapeutic effect, that is, to address a specific disease or health condition. Any concurrent effects outside of this therapeutic outcome are considered undesirable. These undesirable...
1.3K
01:29Microorganisms in Medicine and Therapeutics
35
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
35